|
Market Closed -
Börse Stuttgart
05:55:42 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 11.48 EUR | -1.54% |
|
-11.15% | +125.10% |
| 15/09 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 15/09 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
Company Valuation: GENFIT
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 214.6 | 197 | 176 | 176.3 | 262.2 | 578.3 | - | - |
| Change | - | -8.19% | -10.69% | 0.17% | 48.73% | 120.57% | - | - |
| Enterprise Value (EV) 1 | 30.1 | 131.8 | 168.4 | 156.6 | 166.7 | 527.2 | 510.7 | 541.6 |
| Change | - | 337.75% | 27.79% | -6.98% | 6.41% | 216.33% | -3.12% | 6.05% |
| P/E | 3.51x | -8.27x | -6.1x | 118x | -3.06x | 29.8x | 65.9x | 9.34x |
| PBR | 2.55x | - | 2.59x | 2.54x | - | 7.35x | 8.83x | -47.4x |
| PEG | - | 0x | -0.3x | -1x | 0x | -0x | -1.2x | 0x |
| Capitalization / Revenue | 2.51x | 7.42x | 4.61x | 2.48x | 3.69x | 5.77x | 4.55x | 3.8x |
| EV / Revenue | 0.35x | 4.96x | 4.41x | 2.21x | 2.34x | 5.26x | 4.02x | 3.56x |
| EV / EBITDA | 0.87x | -5.18x | -6.75x | 31.3x | -3.22x | 18.7x | 8.11x | 6.7x |
| EV / EBIT | 0.95x | -4.83x | -6.33x | 47.7x | -37x | 15.4x | 7.22x | 5.95x |
| EV / FCF | 0.3x | - | -3.02x | 10.7x | -6.04x | 26.5x | 37.7x | 13.1x |
| FCF Yield | 330% | - | -33.2% | 9.35% | -16.6% | 3.77% | 2.65% | 7.66% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.23 | -0.48 | -0.58 | 0.03 | -1.72 | 0.3884 | 0.1753 | 1.238 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 85.58 | 26.57 | 38.18 | 70.94 | 71.12 | 100.3 | 127 | 152.3 |
| EBITDA 1 | 34.56 | -25.46 | -24.93 | 5.005 | -51.79 | 28.2 | 62.95 | 80.86 |
| EBIT 1 | 31.82 | -27.29 | -26.58 | 3.281 | -4.5 | 34.31 | 70.69 | 91.01 |
| Net income 1 | 67.26 | -23.72 | -28.89 | 1.507 | -85.97 | 22.88 | 9.067 | 32.84 |
| Net Debt 1 | -184.5 | -65.28 | -7.611 | -19.66 | -95.52 | -51.11 | -67.56 | -36.68 |
| Reference price 2 | 4.32 | 3.97 | 3.54 | 3.54 | 5.26 | 11.56 | 11.56 | 11.56 |
| Nbr of stocks (in thousands) | 49,727 | 49,655 | 49,712 | 49,865 | 49,795 | 50,024 | - | - |
| Announcement Date | 7/4/22 | 13/4/23 | 4/4/24 | 24/4/25 | 2/4/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.88x | 5.74x | 17.19x | 1.02% | 46.28B | |
| 34.31x | 3.31x | 14.29x | -.--% | 43.85B | |
| -19.53x | 224.63x | -20.86x | -.--% | 40.93B | |
| 45.96x | 5.31x | 29.04x | -.--% | 39.89B | |
| 27.09x | 7.81x | 19.95x | 0.42% | 29.5B | |
| 34.82x | 5.71x | 25.95x | -.--% | 17.09B | |
| 25.48x | 2.19x | 9.51x | 1.05% | 15.22B | |
| -55.89x | 9.19x | 224.28x | -.--% | 14.05B | |
| Average | 15.51x | 32.99x | 39.92x | 0.31% | 30.85B | |
| Weighted average by Cap. | 20.30x | 41.76x | 24.53x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Valuation GENFIT
Select your edition
All financial news and data tailored to specific country editions
